Analgesics has been experiencing an upturn in demand in 2022, driven by rising cases of influenza. In addition, the increasing use of analgesics in Germany is also a result of the Omicron variant taking its toll during the year. The emergence of milder variants (and symptoms) of COVID-19 has encouraged demand for OTC analgesics (in addition to cough, cold and (allergy) remedies), particularly ibuprofen, as consumers are more likely to treat themselves at home, without going to the doctor and req...

Euromonitor International’s Analgesics in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.